Navigation Links
Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Management Integrated with SAP(R)
Date:10/28/2008

STATE COLLEGE, Pa., Oct. 28 /PRNewswire/ -- Blue Mountain Quality Resources, Inc. announced today that Alexion Pharmaceuticals has chosen Blue Mountain Regulatory Asset Manager(R) to satisfy their immediate and long-term calibration management needs as part of their enterprise-wide SAP(R) implementation.

"Alexion is committed to high standards for quality and productivity in its manufacturing facilities and other operations," explains Jim Bilotta, CIO of Alexion. "We depend on Blue Mountain to provide best-in-class applications, including a calibration-management solution designed for life sciences, to help us meet regulatory requirements and our own quality objectives."

Companies use Blue Mountain's integration tools between Blue Mountain Regulatory Asset Manager and SAP. This integration means that metrologists using Blue Mountain Regulatory Asset Manager to manage their calibrations can access asset information stored in SAP. At the same time, information about calibration work orders can be viewed from within SAP.

About Alexion Pharmaceuticals

Alexion Pharmaceuticals, Inc., established in 1992, is engaged in discovering, developing and delivering new medicines for patients with severe diseases, including rare disorders. Alexion's first product, Soliris(R) is a first-in-class complement inhibitor (a drug that selectively targets the immune system). Soliris(R), a humanized monoclonal antibody, is approved in the U.S. and Europe as a treatment for paroxysmal nocturnal hemoglobinuria (PNH), a rare, debilitating and life-threatening blood disease. The company is exploring the use of Soliris(R) as a treatment for patients with other rare and severe diseases, and is also developing its ALXN6000 monoclonal antibody as a treatment for patients with chronic lymphocytic leukemia.

About Blue Mountain Quality Resources

Blue Mountain Quality Resources is the validated leader in regulatory asset management. Blue Mountain Regulatory Asset Manager, the company's flagship software product, is a comprehensive integrated browser-based solution designed to enable the maintenance, calibration and quality personnel to manage the validated state of assets and processes. With 15 years of experience in FDA-regulated and ISO-compliant markets and over 1000 life science implementations, Blue Mountain offers a complete solution from set-up and installation to training and validation, including integration with a broad range of enterprise applications.

For more information about Blue Mountain Regulatory Asset Manager visit http://www.coolblue.com/Products/cm_sap.htm or contact Blue Mountain Quality Resources, Inc. at 800-982-2388, +1-814-234-2417 or ram@coolblue.com.

SAP is the registered trademarks(s) of SAP AG in Germany and in several other countries.

Soliris is the registered trademark of Alexion Pharmaceuticals, Inc.

Blue Mountain Regulatory Asset Manager is the registered trademark of Blue Mountain Quality Resources, Inc.

Contact:

Bryce Johannes

Director of Marketing

814-234-2417 x122

marketing@coolblue.com


'/>"/>
SOURCE Blue Mountain Quality Resources, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Alexion to Present at the Goldman Sachs 29th Annual Global Healthcare Conference
2. Alexion to Present at the Morgan Stanley Global Healthcare Unplugged Conference
3. Alexion Pharmaceuticals Invites You to Participate in its First Quarter 2008 Results Conference Call and Web Cast
4. Alexion to Present at Investor Conferences
5. Alexion Pharmaceuticals to Present Data on Soliris(R) (Eculizumab) and PNH at the 2007 American Society of Hematology (ASH) Annual Meeting
6. Alexion to Present at Investor Conferences
7. Alexion Pharmaceuticals Invites You to Participate in its Third Quarter 2007 Results Conference Call and Web Cast
8. Perrigo Company Licenses Prescription Brands to Medimetriks Pharmaceuticals
9. CoLucid Pharmaceuticals Names Linda Hogan VP of Business Development
10. Anadys Pharmaceuticals to Present at Bio Investor Forum
11. Memory Pharmaceuticals Announces Issuance of Key U.S. Patent for R3487/MEM 3454 and R4996/MEM 63908
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The TouchPoint Solution, home of ... manage stress and anxiety. , “Buzzies change the way we interact with stress ... Buzzies. , Since its launch date in December 2016, The TouchPoint Solution has sold ...
(Date:3/23/2017)... CA (PRWEB) , ... March 23, 2017 , ... ... management and workflow solutions, today named The Resource Group as their 2016 Microsoft ... and partner conference in Newport Beach, CA. The award recognizes The Resource ...
(Date:3/23/2017)... ... 23, 2017 , ... According to the National Sleep Foundation , poor ... the only cause of the sunken-eye look, which can include dark circles or bags ... poor health are likely due to genetics, dehydration, allergies, and losing fat beneath the ...
(Date:3/23/2017)... CA (PRWEB) , ... March 23, 2017 , ... ... FACIS Monthly Monitoring Healthcare products at competitive pricing. Verisys through ... sanctions, Exclusions, Debarments, License restrictions and Disciplinary actions. , “We are delighted to ...
(Date:3/23/2017)... ... March 23, 2017 , ... On 2 March ... the US Special Operations Command’s Patriot Award. The award was presented by the ... Force Dagger Foundation for its significant and enduring support to the command. ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017   Icertis , the leading ... the cloud, today announced an upgrade to the ... to improve clinical trials contract management. Built on ... the solution speeds up clinical trial contracting while ... (CRO). "The pharmaceutical industry is ...
(Date:3/23/2017)... 23, 2017  Interpace Diagnostics Group, Inc. (NASDAQ: ... integrated commercial company that provides clinically useful molecular ... it has entered into agreements to successfully restructure ... ("RedPath") and concurrently terminate its royalty and milestone ... debt to RedPath amounting to $9.34 million is ...
(Date:3/23/2017)... 2017  Additive Orthopaedics, LLC., an early stage ... kicked off a multi-centered clinical study to measure ... According to Brian McLaughlin , ... structures have already shown tremendous post-operative success and ... wedges from which we have seen evidence of ...
Breaking Medicine Technology: